Prostate Cancer Awareness and Initiative for Screening in the European Union (PRAISE-U)
Sponsor: Althaia Xarxa Assistencial Universitària de Manresa
This observational or N/A phase trial investigates Prostate Cancer and is currently ongoing. Althaia Xarxa Assistencial Universitària de Manresa leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Sep 2024 — Sep 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Althaia Xarxa Assistencial Universitària de Manresa
- Conselleria de Sanidade de Galicia
- Czech Urological Society
- Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii
- EUROPEAN CANCER ORGANISATION
- Erasmus Medical Center
- Estonian Urological Association
- Europa UOMO
- European Association of Urology Research Foundation
- European Randomised Study of Screening for Prostate Cancer
- European Society of Urogenital Radiology
- Health Service Executive, Ireland
- Institute of Health Information and Statistics of the Czech Republic
- International Agency for Research on Cancer
- Movember Foundation
- Narodowy Instytut Zdrowia Publicznego
- National Cancer Institute (NCI)
- Region MidtJylland Denmark
- Region Skane
- UMC Utrecht
- University College Dublin
- University Ghent
- Vastra Gotaland Region
- WONCA Europe
For direct contact, visit the study record on ClinicalTrials.gov .